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Tuberculosis (TB) is a major health problem 
worldwide, particularly in developing countries. One 
of the health targets set in the 2010 Millennium 
Development Goals is to halt and reverse the 
incidence of TB by 2015.[1]
South Africa (SA) has one of the highest TB burdens in the world, 
ranked third after India and China.[2] The spread of the TB epidemic 
is closely related to high HIV infection rates, particularly in sub-
Saharan Africa, where 82% of TB-HIV co-infection is found.[3]
Disseminated tuberculosis
Disseminated TB is defined as TB that involves two or more non-
contiguous sites.[4] The clinical presentation may be chronic and 
nonspecific (with signs and symptoms such as fever, weight loss, 
anorexia and weakness) or acute (as fulminant disease). Clinical 
signs depend on organ involvement and, in order of frequency, 
include hepatomegaly, pulmonary findings, lymphadenopathy and 
splenomegaly. Children have a much higher risk of developing 
active TB, while disseminated TB is seen more frequently in children 
<1 year old.[5] 
Disseminated TB requires accurate and early diagnosis, given that 
it is an increasingly significant cause of morbidity and mortality 
in developing countries, particularly in sub-Saharan Africa, where 
patients are likely to be co-infected with HIV. In areas where TB and 
HIV are endemic, TB septicaemia is among the leading causes of 
bloodstream infection. Moreover, TB is often neglected as a cause of 
death in cases of AIDS,[6] where the mortality rate in children has been 
reported to be as high as 18 - 30%.[7] 
The diagnosis of disseminated TB can be made on sputum or 
gastric washings through isolation of the Mycobacterium tuberculosis 
(Mtb) bacilli. It may, however, be missed using these samples, and 
therefore more invasive investigations such as bronchoscopy, bone 
marrow biopsy and liver biopsy are required.[7] The International 
Standards for TB Care recommend that, where the facilities and 
resources are available, appropriate specimens should be obtained 
for microscopy, culture and histopathological examinations from 
suspected sites of involvement in patients with presumed extra-
pulmonary/disseminated TB.[8]
Several factors obstruct diagnosis of disseminated TB in children. 
Obtaining sputum is difficult, leaving clinicians to resort to gastric 
aspirates. However, identification of acid-fast bacilli (AFB) on gastric 
aspirates is positive in less than 15% of samples, and only 30 - 40% 
are positive on culture.[5,9]
The tuberculin skin test (TST) similarly has many limitations. 
While reactive in most children within 3 - 6 weeks after initial 
infection, a positive reaction may be delayed for up to 3 months. False 
negative TSTs occur in up to 10% of children who are TB-culture 
positive, particularly in the context of severe TB illness, malnutrition, 
immunosuppression and the presence of other severe infections. 
Furthermore, asymptomatic infections caused by environmental 
non-tuberculous mycobacteria can give false positive results.[10] 
Ker et al.[11] conducted a prospective study in HIV-positive adult 
patients, comparing bone marrow studies with peripheral blood 
culture in the diagnosis of disseminated TB. They showed a higher 
diagnostic yield when bone marrow examination and peripheral 
blood culture were used in parallel. When disseminated TB is 
suspected in immune-competent adults, blood culture offers a safer, 
less invasive and cheaper investigation than bone marrow biopsy. 
However, a positive blood culture is rare.[12] Alternatively, a bone 
marrow aspirate can be cultured for AFB and other organisms. In 
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addition, bone marrow trephine biopsy may show granulomas that 
may reveal AFB following Ziehl-Neelsen (ZN) staining. Positive 
bone marrow trephine results become available within 24 - 48 hours.
[13] However, in children, the paucibacillary nature of the disease makes 
detecting mycobacteria difficult.
To our knowledge, there has been only one prospective study 
comparing bone marrow investigation with peripheral blood culture 
in the diagnosis of disseminated TB in a paediatric cohort.[14] The study 
concluded that both modalities are useful in confirming disseminated 
TB in children. 
Methodology 
A prospective study was conducted from October 2007 to October 
2008 at Tygerberg Hospital in Cape Town, in collaboration with 
the Division of Microbiology and Department of Paediatrics. Ethics 
approval was granted.
The study primarily aimed to evaluate the role of bone marrow 
biopsies in the diagnosis of disseminated TB in paediatric patients 
admitted to the hospital. Secondary aims were to compare peripheral 
blood cultures with aspirate cultures, identify AFB on trephine 
biopsies, compare the peripheral blood counts and morphological 
features of HIV-negative and -positive patients, and demonstrate the 
morphological findings of bone marrow biopsies in HIV-negative 
and -positive children.
Patients were recruited from Tygerberg Hospital and from outpatient 
clinics and referring hospitals, on the basis of being 13 years old or 
younger and having suspected disseminated TB. Consent was obtained 
from parents/legal guardians. Exclusion criteria included diagnosis of 
disseminated TB already confirmed by other means; lack of consent; 
severe illness and therefore inability to tolerate the bone marrow 
procedure; or showing signs of responding to TB treatment. 
The Department of Paediatrics was responsible for taking histories 
and for physical examination, which included anthropometry and 
systemic examinations. The work-up of the patient encompassed 
Mantoux testing; chest X-ray; blood sampling for full blood counts, 
HIV test and blood culture; gastric washings and/or sputa for 
microscopy, culture and sensitivity and ZN stain; abdominal 
ultrasound; and cerebrospinal fluid analysis. 
Peripheral blood and bone marrow aspirates and trephine 
biopsies were obtained under local anaesthetic and sedation. 
Samples were inoculated into BACTEC Myco/F-Lytic bottles (BD, 
Franklin Lakes, NJ, USA) then subcultured into Löwenstein-
Jensen solid media and incubated aerobically for 6 weeks. 
Cultures that were positive were confirmed as Mtb or other 
mycobacterial species by polymerase chain reaction (PCR). Slides 
of the peripheral blood and bone marrow aspirates were stained 
using Romanowsky and May-Grünwald Giemsa (MGG) stains 
respectively; the trephine biopsy was decalcified, fixed, embedded 
in wax, cut, trimmed and stained using haematoxylin and eosin 
(H&E), MGG and reticulin stains. Each trephine biopsy specimen 
was examined to assess cellularity, haematopoietic maturation, and 
for presence of dysplastic changes, stromal changes, granulomas 
or any other pathology. ZN staining was performed on biopsies 
containing granulomas to identify AFB.
Results
A total of 45 patients with suspected disseminated TB were evaluated 
for the study. Ten were excluded, 8 because consent was not obtained 
and 2 following confirmation of disseminated TB by other means. 
Thus, 35 patients were enrolled. The diagnosis of TB was confirmed 
in 25 patients, 19 of whom had positive cultures (gastric washings/
sputum, blood or aspirate) and/or granulomas on histology (Table 1), 
while 6 patients were classified as having probable TB and treated as 
such, based on clinical suspicion and miliary pattern on chest X-ray, 
but in the absence of laboratory confirmation. Of the 25 patients 
with mycobacterial disease, 20 were diagnosed with disseminated TB 
while 5 had TB confined to a single site. Mtb was the causative agent 
in 84% (16/19) of confirmed cases. 
Granulomas were identified in 11% (5/35) of all bone marrow 
trephine biopsies (Fig. 1), 4 of which showed ZN positivity, and in 20% 
(5/25) of HIV-positive patients who were subsequently confirmed 
to have TB. Of note, 81% (22/25) of patients diagnosed with TB 
had already started TB treatment at time of bone marrow biopsy. 
Meanwhile, 22% of HIV-positive patients showed granulomas on 
trephine biopsy compared with 10% in the HIV-negative population 
(Figs 2 and 3). 
Peripheral blood cultures were positive in less than 1% (1/35) and 
bone marrow aspirate cultures were positive in less than 5% (3/35) of 
the patients (Fig. 4). An HIV test was not performed in 6% (2/35) of 
patients, 60% (21/35) tested negative for HIV, and 34% (12/35) were 
positive (Fig. 5).
Anaemia, thrombocytosis/thrombocytopenia were the main 
peripheral blood findings: anaemia in 26% (9/35), thrombocytosis 
in 17% (6/35) and thrombocytopenia in 17% (6/35). In HIV-positive 
patients, peripheral blood findings were as follows: anaemia (25%), 
pancytopenia (25%), thrombocytopenia (25%), bicytopenia (17%), 
and leukopenia (8%). In contrast, HIV-negative patients presented 
with anaemia (27%), thrombocytosis (27%), thrombocytopenia 
(27%), bicytopenia (14%) and pancytopenia (9%). Of the HIV-
negative patients, 9% had normal counts. No patients in the HIV-
positive group showed normal counts or thrombocytosis (Table 2). 
The peripheral blood morphology of our study group showed the 
following: 46% showed features of infection, 29% were normal and 
14% showed dysplastic features. 
Of the HIV-positive patients, 42% showed dysplasia; no dysplasia 
was noted in the peripheral blood smear of HIV-negative patients 
(Table 3).
The bone marrow biopsy morphological features were as follows: 
51% were normal (18/35), 25% showed secondary myelodysplasia 
(9/35), 10% showed mild dysplastic features (4/35), 3% aplastic 
anaemia (1/35), and 3% showed eosinophilia (1/35). In 3% (1/35), 
the biopsy was suboptimal for interpretation, and in 3% (1/35) 
examination was not carried out. Of the patients with HIV, 64% 
showed HIV-associated myelodysplasia; myelodysplastic features 
were not seen in any of the HIV-negative patients (Figs 2 and 3). 
No complications related to the bone marrow occurred. Bone 
marrow trephine biopsy results were communicated to the clinician 
within 48 hours of the procedure. TB was excluded confidently in 
10 patients. 
Table 1. Comparison of the diagnostic yield of the specimens collected for the diagnosis of TB
Total patients (N)
Gastric washings  
culture positive (n)
Peripheral blood  
culture positive (n)
Aspirate culture 
positive (n) ZN-positive granulomas (n)
35 17 1 3 4
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Discussion
Because disseminated TB is fatal if not diagnosed early, strong clinical 
suspicion of the condition, confirmation of the diagnosis and urgent 
institution of treatment are necessary. As the diagnosis of disseminated 
TB is often missed on sputum, more invasive investigations are 
required.[7] Unfortunately, our study sample was too small to show any 
statistical significance. Disseminated TB was diagnosed on the basis 
of the presence of granulomas in 11% of patients undergoing trephine 
biopsy. The yield was even greater, at 20%, in those patients who were 
HIV-positive and in whom TB was finally confirmed. 
The main disadvantage of our study was that most patients 
had already started TB treatment when bone marrow biopsy was 
performed. According to Rose et al., respiratory specimens sent for 
culture before treatment is initiated provide the best mycobacterial 
culture yield at 49%; the diagnostic yield of the trephine biopsy is 
much lower in comparison.[15] We therefore speculate that the low 
rate of detection of AFB on the trephine biopsy might have been 
influenced by our patients starting treatment before referral for a 
bone marrow biopsy, rather than risk delay in commencing treatment 
for disseminated TB. Rose et al. noted also that the 4- to 6-week 
Table 2. Comparison of peripheral blood counts of HIV-
negative and HIV-positive patients
HIV-negative (%) HIV-positive (%)
Normal 9 0
Anaemia 27 25
Thrombocytopenia 14 25
Leucopenia 0 8
Bicytopenia 14 17
Pancytopenia 9 25
Thrombocytosis 27 0
Table 3. Comparison of peripheral blood morphology features
HIV-negative (%) HIV-positive (%)
Normal 43 8
Features of infection 44 50
Dysplastic features 0 42
Not done 13 0
Fig. 5. HIV status of patient cohort: 34% (12/35) of patients were HIV-positive, 
60% (21/35) were HIV-negative and 6% (2/35) were not tested for HIV.
NEG
60%
ND
6%
POS
34%
Fig. 4. Comparison of peripheral blood cultures (B/culture) and bone marrow 
aspirate cultures (BM TB culture): most samples were negative for TB.
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25
20
15
10
5
0
B/Culture
BM TB Culture
Negative Positive MTB Not Done Contaminated
Fig. 1. Granulomas on trephine biopsies: 11% of the patients showed 
granulomas on the trephine biopsy.
11%
31%
52%
3% 3%
Normal Granulomas Abnormal Suboptimal Not Done
Fig. 2. Bone marrow morphology findings of HIV-positive patients: 64% of 
patients with HIV showed HIV-related myelodyplastic changes (2nd MDS).
64%
7% 7%
22%
Normal Mild dysplastic features Granulomas 2nd MDS
Fig. 3. Bone marrow morphology findings in HIV-negative patients: 76% of 
HIV-negative patients had normal marrows.
14%
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Normal Mild dysplastic features Granulomas
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waiting period for positive Mtb culture results was too prolonged 
to influence TB management.[15] In contrast, in our study, results of 
the bone marrow trephine biopsy were available within 48 hours 
and therefore treatment with anti-TB drugs could be implemented 
immediately in 4 patients. 
David et al. assessed the role of peripheral blood cultures in the 
diagnosis of adult TB, and confirmed TB in 19% (15/80) of their 
patients.[16] In our study, in comparison, peripheral blood and bone 
marrow aspirate cultures showed an extremely low Mtb yield. The lack 
of standardisation for collecting these samples, the variety of clinical 
personnel involved in sample collection and the paucibacillary nature 
of the disease in children are all underlying explanations for this very 
low Mtb yield. Evidence suggests that bone marrow aspirate cultures 
are more sensitive than peripheral blood cultures for the diagnosis of 
disseminated TB.[11] We also demonstrated that complete evaluation 
of bone marrow aspirate and trephine biopsies provides a higher 
diagnostic yield.
As further support for performing a bone marrow biopsy, we were 
able to provide an explanation for the cytopenias in our HIV-positive 
patients. HIV-related myelodysplasia is a well-known phenomenon 
and is known to contribute towards cytopenias.[17] The majority of our 
HIV-positive patients were diagnosed with an HIV-related secondary 
myelodysplastic syndrome, while none of our HIV-negative patients 
showed such features. In addition, our HIV-positive patients showed a 
higher percentage of granulomas than those who were HIV-negative. 
Cucin et al. compared the roles of liver biopsy and bone marrow 
biopsy in the diagnosis of disseminated TB, and concluded that bone 
marrow biopsy was less hazardous.[18] We can recommend bone marrow 
trephine and biopsy as a safe procedure since no complications 
occurred in our patients. 
Conclusion
In conclusion, a low threshold for undertaking bone marrow aspirate 
and trephine is recommended to confirm the diagnosis in patients 
in whom HIV positivity, cytopenias, organomegaly and fever arouse 
suspicion of disseminated TB. 
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